These mutations have been found to cause excessive activation of NF-κB and MAPK compared to the wild-type NOD2, leading to the hypothesis that Blau syndrome is the result of gain-of-function NOD2 [126]. This evidence concerns the gene NOD2 and Blau syndrome.